STAT5A and ovarian carcinoma: The findings presented here provide evidence of synergy between NF-κB and STAT5 in transcriptional activation of Bcl-xL in ovarian cancer cells, and also indicate potential molecular pathways to be targeted in order to enhance chemotherapeutic effects.